News

Skills and TrainingNew survey shows UK cell and gene therapy industry expects workforce to return to growth, following a challenging period of headcount reductions
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
ReNeuron wins grant for retinal cell therapy developmentReNeuron wins grant for retinal cell therapy developmentRegulatory news - March 2018Regulatory news - March 2018Press release: CGT Catapult to support UK network of Advanced Therapy Treatment CentresPress release: CGT Catapult to support UK network of Advanced Therapy Treatment CentresFebruary newsletterFebruary newsletterCGT Catapult holds inaugural Seminar SeriesCGT Catapult holds inaugural Seminar SeriesRegulatory news - February 2018Regulatory news - February 2018Press Release: Cell and Gene Therapy Catapult enters into partnership with the Japanese Society for Regenerative MedicinePress Release: Cell and Gene Therapy Catapult enters into partnership with the Japanese Society for Regenerative MedicineRegulatory news - January 2018Regulatory news - January 2018January newsletterJanuary newsletterRexgenero secures Innovate UK grantRexgenero secures Innovate UK grantPress release: CGT Catapult announces viral vector manufacturing technology collaboration with Freeline TherapeuticsPress release: CGT Catapult announces viral vector manufacturing technology collaboration with Freeline TherapeuticsPress Release: CGT Catapult and CombiGene sign agreement to develop manufacturing process for novel gene therapy to treat epilepsyPress Release: CGT Catapult and CombiGene sign agreement to develop manufacturing process for novel gene therapy to treat epilepsy